Talk's title: TBC

Nicolás Gómez Banoy is an endocrinologist-scientist with a longstanding interest in understanding the pathophysiology of cardiometabolic diseases and treating patients affected by these conditions. He is originally from Bogotá, Colombia, where he trained as a physician at the Universidad Nacional de Colombia. There, he conducted research to identify circulating biomarkers of diabetic kidney disease under the guidance of Professor Ismena Mockus. He then moved to New York City, United States, to work as a postdoctoral fellow in the laboratory of Dr. James Lo at Weill Cornell Medicine. There, he worked in pancreatic islet biology and uncovered the role of a complement factor in regulating the survival and identity of insulin-producing beta cells in the context of diabetes. He subsequently trained as an internist and endocrinologist at Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center. During his endocrine fellowship, he began working at The Rockefeller University under the mentorship of Dr. Paul Cohen, and he has now transitioned to the role of Instructor of Clinical Investigation at Rockefeller. His broad interest lies in the biological mechanisms that govern adipose tissue and its potential as a therapeutic target in cardiometabolic diseases and cancer. He specifically studies the genetic and pharmacologic determinants of brown adipose tissue using a reverse translational approach. Ultimately, his goal is to understand whether thermogenic adipocytes are biomarkers of metabolic health in humans or whether they can be harnessed to treat cardiometabolic disorders. His work and trajectory have been recognized with an Emerging Generation Award from the American Society of Clinical Investigation, a Career Award for Medical Scientists from the Burroughs Wellcome Fund, and an invited talk at the Rising Stars in Metabolism Symposium at the University of Utah, among others.